著者検索結果

1

Defining the neurocircuitry of exercise hyperpnoea 著者: David J. Paterson

出版事項 2013

全文の入手
Revisão

お気に入りに追加

保存先:
2

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) 著者: David L. Paterson

出版事項 2000

全文の入手
Revisão

お気に入りに追加

保存先:
3

Impact of Antibiotic Resistance in Gram‐Negative Bacilli on Empirical and Definitive Antibiotic Therapy 著者: David L. Paterson

出版事項 2008

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
4

The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species 著者: David L. Paterson

出版事項 2006

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
5

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy 著者: David L. Paterson

出版事項 2004

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
6

The Role of Antimicrobial Management Programs in Optimizing Antibiotic Prescribing within Hospitals 著者: David L. Paterson

出版事項 2005

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
7

Neuromodulators of peripheral cardiac sympatho‐vagal balance 著者: Neil Herring, David J. Paterson

出版事項 2008

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
8

ENCEPHALITIS CAUSED BY HUMAN HERPESVIRUS-6 IN TRANSPLANT RECIPIENTS 著者: Nina Singh, David L. Paterson

出版事項 2000

全文の入手
Artigo

お気に入りに追加

保存先:
9

Carbapenemase-Producing Enterobacteriaceae 著者: David L. Paterson, Yohei Doi

出版事項 2015

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
10

Invasive Aspergillosis in Transplant Recipients 著者: David L. Paterson, Nina Singh

出版事項 1999

全文の入手
Revisão

お気に入りに追加

保存先:
11

Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients 著者: Yuki Hayashi, David L. Paterson

出版事項 2011

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
12

Setting and Revising Antibacterial Susceptibility Breakpoints 著者: John Turnidge, David L. Paterson

出版事項 2007

全文の入手
Revisão

お気に入りに追加

保存先:
13

<i>Aspergillus</i>Infections in Transplant Recipients 著者: Nina Singh, David L. Paterson

出版事項 2005

全文の入手
Revisão

お気に入りに追加

保存先:
14

Interactions Between Tacrolimus and Antimicrobial Agents 著者: David L. Paterson, Nina Singh

出版事項 1997

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
15

Detection of plasmid-mediated class C β-lactamases 著者: Yohei Doi, David L. Paterson

出版事項 2007

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
16

A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative Bacilli 著者: David L. Paterson, Yohei Doi

出版事項 2007

全文の入手全文の入手
Carta

お気に入りに追加

保存先:
17

Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig <i>in vitro</i> 著者: Neil Herring, David J. Paterson

出版事項 2001

全文の入手全文の入手
Artigo

お気に入りに追加

保存先:
18

Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 著者: Marco Falcone, David L. Paterson

出版事項 2016

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
19

Antibiotics in the clinical pipeline in October 2019 著者: Mark S. Butler, David L. Paterson

出版事項 2020

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:
20

Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control 著者: Alexander L. Green, David J. Paterson

出版事項 2008

全文の入手全文の入手
Revisão

お気に入りに追加

保存先:

検索結果 - David S. Paterson

Defining the neurocircuitry of exercise hyperpnoea 著者: David J. Paterson

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) 著者: David L. Paterson

Impact of Antibiotic Resistance in Gram‐Negative Bacilli on Empirical and Definitive Antibiotic Therapy 著者: David L. Paterson

The Epidemiological Profile of Infections with Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter Species 著者: David L. Paterson

“Collateral Damage” from Cephalosporin or Quinolone Antibiotic Therapy 著者: David L. Paterson

The Role of Antimicrobial Management Programs in Optimizing Antibiotic Prescribing within Hospitals 著者: David L. Paterson

Neuromodulators of peripheral cardiac sympatho‐vagal balance 著者: Neil Herring, David J. Paterson

ENCEPHALITIS CAUSED BY HUMAN HERPESVIRUS-6 IN TRANSPLANT RECIPIENTS 著者: Nina Singh, David L. Paterson

Carbapenemase-Producing Enterobacteriaceae 著者: David L. Paterson, Yohei Doi

Invasive Aspergillosis in Transplant Recipients 著者: David L. Paterson, Nina Singh

Strategies for Reduction in Duration of Antibiotic Use in Hospitalized Patients 著者: Yuki Hayashi, David L. Paterson

Setting and Revising Antibacterial Susceptibility Breakpoints 著者: John Turnidge, David L. Paterson

<i>Aspergillus</i>Infections in Transplant Recipients 著者: Nina Singh, David L. Paterson

Interactions Between Tacrolimus and Antimicrobial Agents 著者: David L. Paterson, Nina Singh

Detection of plasmid-mediated class C β-lactamases 著者: Yohei Doi, David L. Paterson

A Step Closer to Extreme Drug Resistance (XDR) in Gram-Negative Bacilli 著者: David L. Paterson, Yohei Doi

Nitric oxide‐cGMP pathway facilitates acetylcholine release and bradycardia during vagal nerve stimulation in the guinea‐pig <i>in vitro</i> 著者: Neil Herring, David J. Paterson

Spotlight on ceftazidime/avibactam: a new option for MDR Gram-negative infections 著者: Marco Falcone, David L. Paterson

Antibiotics in the clinical pipeline in October 2019 著者: Mark S. Butler, David L. Paterson

Identification of neurocircuitry controlling cardiovascular function in humans using functional neurosurgery: implications for exercise control 著者: Alexander L. Green, David J. Paterson

検索ツール:

関連主題